Product image of Nocutil (Desmopressin Acetate) supplied by GNH India

Nocutil

Active Ingredient:
Desmopressin Acetate
Origin:
EU

Nocutil (Desmopressin Acetate)

Desmopressin, the active ingredient in Nocutil, is a vasopressin analog presented as a nasal spray for nasal use. It treats central diabetes insipidus, nocturnal enuresis, hemophilia A and von Willebrand disease in appropriate patients.

GNH India supplies Nocutil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gebro Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin acts on the antidiuretic hormone pathway to manage water balance and bleeding disorders.

  • Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption.
  • Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents.
  • Hemophilia A: raises plasma factor VIII levels to improve clot formation.
  • Von Willebrand disease: elevates von Willebrand factor, helping control mucosal bleeding.

How It Works

  • Desmopressin is a synthetic analogue of vasopressin that selectively binds V2 receptors on the basolateral membrane of renal collecting‑duct cells. Activation of V2 receptors stimulates adenylate cyclase, increasing cyclic AMP, which promotes insertion of aquaporin‑2 water channels into the apical membrane, enhancing water reabsorption. The same V2 stimulation in endothelial cells raises plasma concentrations of factor VIII and von Willebrand factor, providing a hemostatic effect.

Side Effects

Desmopressin nasal spray may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Nasal irritation: mild burning or dryness at the application site.
  • Headache: transient mild to moderate pain.
  • Hyponatremia: mild reduction in serum sodium, often asymptomatic.
  • Flushing: brief warmth or redness of the skin.

Serious or Rare Side Effects

  • Severe hyponatremia: can lead to seizures or coma.
  • Thromboembolic events: rare clot formation in veins or arteries.
  • Allergic reaction: rash, itching, or swelling of the face.
  • Water intoxication: excessive fluid retention causing edema.

Precautions & Warnings

Before prescribing desmopressin nasal spray, clinicians should consider several safety precautions.

  • Assess fluid balance: ensure patients are not over‑hydrated to avoid hyponatremia.
  • Monitor serum sodium: check electrolytes regularly, especially in the elderly or those on diuretics.
  • Evaluate renal function: impaired kidneys may alter drug clearance.
  • Caution in cardiac disease: fluid retention can exacerbate heart failure.
  • Avoid concomitant ADH‑active drugs: limit use with carbamazepine or SSRIs.
  • Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Desmopressin nasal spray can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Concomitant use with carbamazepine: may reduce desmopressin effectiveness.
  • Combination with selective serotonin reuptake inhibitors (SSRIs): increases risk of hyponatremia.
  • Co‑administration with diuretics (especially thiazides): heightens fluid retention and electrolyte disturbances.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may potentiate antidiuretic effect, requiring sodium monitoring.
  • Anticoagulants (e.g., warfarin): enhanced hemostatic effect may alter bleeding risk.
  • Hormonal contraceptives: possible additive effect on water retention.

Frequently Asked Questions

Nocutil, containing desmopressin, is prescribed for central diabetes insipidus to reduce excessive urine output, for nocturnal enuresis to lessen nighttime bedwetting, and for certain bleeding disorders such as hemophilia A and von Willebrand disease where it helps raise clotting factor levels.

Desmopressin mimics the natural hormone vasopressin and selectively activates V2 receptors in the kidneys. This triggers a cascade that moves water channels to the cell surface, allowing more water to be reabsorbed. In blood vessels, the same activation raises factor VIII and von Willebrand factor, aiding clot formation.

The dose of Nocutil is individualized. A qualified prescriber determines the appropriate amount, frequency, and duration based on the patient’s specific condition, age, renal function, and response to therapy. Patients should follow the prescribing information provided by their healthcare professional.

Safety data for desmopressin in pregnancy and lactation are limited. The product is classified as pregnancy category unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Nocutil.

To order Nocutil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Nocutil (desmopressin) is a synthetic vasopressin analogue that offers a longer half‑life and greater selectivity for V2 receptors than natural vasopressin, resulting in fewer vasoconstrictive side effects. Compared with other antidiuretic drugs, it provides both antidiuretic and hemostatic benefits, making it useful for bleeding disorders as well as water‑balance disorders.

Nocutil nasal spray should be stored at room temperature, below 25 °C. Keep the device in its original packaging, protect it from moisture and direct sunlight, and ensure the spray tip remains clean. Do not freeze the product.

Nocutil is delivered as a nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and press the actuator to deliver the prescribed number of sprays. The dose may be repeated in the other nostril if required, and the device should be cleaned according to the label instructions.

The most serious risks include severe hyponatremia, which can cause seizures, coma, or death, and water intoxication leading to cerebral edema. Rarely, thromboembolic events or serious allergic reactions may occur. Patients should be monitored for sudden changes in weight, headache, nausea, or confusion, and serum sodium should be checked regularly.

Nocutil should be avoided in individuals with known hypersensitivity to desmopressin or any component of the formulation, in patients with uncontrolled hyponatremia, severe renal impairment, or uncontrolled heart failure. Caution is also advised for those taking drugs that affect water balance, such as certain diuretics or antidepressants, unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desmopressin Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT